Plain Language Summary
Plain Language Summary
As part of Jazz’s commitment to putting patients first, we are providing plain language summaries for certain clinical trials below. These plain language summaries provide clinical trial results in an easy-to-understand format so all patients can obtain more information on the study results.
| Study | Title |
| HERIZON-BTC-01 | A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers (HERIZON-BTC-01) |
| CREST UK | CREST UK: CPX-351 Real-World Effectiveness and Safety Study |
Disclaimer: The purpose of plain language summaries is to provide clinical trial results in an easy-to-understand format. Plain language summaries are not intended for any promotional purposes or as a replacement or substitute for medical advice provided by your doctor or healthcare provider. It is important for you to discuss your treatment options, and any questions that you may have, with your doctor or healthcare provider. You should not use this website to diagnose or treat a health problem or disease.